229 related articles for article (PubMed ID: 26774881)
21. XRCC5 cooperates with p300 to promote cyclooxygenase-2 expression and tumor growth in colon cancers.
Zhang Z; Zheng F; Yu Z; Hao J; Chen M; Yu W; Guo W; Chen Y; Huang W; Duan Z; Deng W
PLoS One; 2017; 12(10):e0186900. PubMed ID: 29049411
[TBL] [Abstract][Full Text] [Related]
22. C5a induces A549 cell proliferation of non-small cell lung cancer via GDF15 gene activation mediated by GCN5-dependent KLF5 acetylation.
Zhao C; Li Y; Qiu W; He F; Zhang W; Zhao D; Zhang Z; Zhang E; Ma P; Liu Y; Ma L; Yang F; Wang Y; Shu Y
Oncogene; 2018 Aug; 37(35):4821-4837. PubMed ID: 29773900
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2 up-regulates vascular endothelial growth factor via a protein kinase C pathway in non-small cell lung cancer.
Luo H; Chen Z; Jin H; Zhuang M; Wang T; Su C; Lei Y; Zou J; Zhong B
J Exp Clin Cancer Res; 2011 Jan; 30(1):6. PubMed ID: 21219643
[TBL] [Abstract][Full Text] [Related]
24. Proanthocyanidins inhibit in vitro and in vivo growth of human non-small cell lung cancer cells by inhibiting the prostaglandin E(2) and prostaglandin E(2) receptors.
Sharma SD; Meeran SM; Katiyar SK
Mol Cancer Ther; 2010 Mar; 9(3):569-80. PubMed ID: 20145019
[TBL] [Abstract][Full Text] [Related]
25. [Role of COX-2/PGE2/EP4 Axis-induced Macrophage Functional Activation
in NSCLC Development].
Zhao J; Zhu Q; Zhang Y; Li G; Zhang Y; Li F; Bian L
Zhongguo Fei Ai Za Zhi; 2024 Apr; 27(4):245-256. PubMed ID: 38769827
[TBL] [Abstract][Full Text] [Related]
26. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
27. [Cloning, ligation and expression of the variable region genes of the monoclonal antibody against human HnRNPA2/B1].
Wang X; Peng XD; Li G; Hu LJ; Bi JH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):548-51. PubMed ID: 15583979
[TBL] [Abstract][Full Text] [Related]
28. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
29. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.
Chung LY; Tang SJ; Sun GH; Chou TY; Yeh TS; Yu SL; Sun KH
Clin Cancer Res; 2012 Aug; 18(15):4037-47. PubMed ID: 22696230
[TBL] [Abstract][Full Text] [Related]
30. Lentivirus-mediated shRNA interference targeting cyclooxygenase-2 inhibits growth of human non-small cell lung cancer.
Li T; Lu J; Zhong Y
J BUON; 2013; 18(4):908-14. PubMed ID: 24344016
[TBL] [Abstract][Full Text] [Related]
31. [Role of heterogeneous nuclear ribonucleoprotein A2/B1 protein in the pathogenesis of non-small cell lung cancer].
Shi Y; Chen Y; Hou YY; Ji CH; Hu Q; Zhou Y; Su JA; Tan YS
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):110-4. PubMed ID: 21575478
[TBL] [Abstract][Full Text] [Related]
32. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer.
Zech VF; Dlaska M; Tzankov A; Hilbe W
Cancer Detect Prev; 2006; 30(5):395-402. PubMed ID: 17067748
[TBL] [Abstract][Full Text] [Related]
33. Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-inducible factor-1alpha in non-small cell lung cancer.
Csiki I; Yanagisawa K; Haruki N; Nadaf S; Morrow JD; Johnson DH; Carbone DP
Cancer Res; 2006 Jan; 66(1):143-50. PubMed ID: 16397226
[TBL] [Abstract][Full Text] [Related]
34. hnRNPA2/B1 and nELAV proteins bind to a specific U-rich element in CDK5R1 3'-UTR and oppositely regulate its expression.
Zuccotti P; Colombrita C; Moncini S; Barbieri A; Lunghi M; Gelfi C; De Palma S; Nicolin A; Ratti A; Venturin M; Riva P
Biochim Biophys Acta; 2014 Jun; 1839(6):506-16. PubMed ID: 24792867
[TBL] [Abstract][Full Text] [Related]
35. The cyclin-dependent kinase 2 inhibitor down-regulates interleukin-1beta-mediated induction of cyclooxygenase-2 expression in human lung carcinoma cells.
Mukhopadhyay P; Ali MA; Nandi A; Carreon P; Choy H; Saha D
Cancer Res; 2006 Feb; 66(3):1758-66. PubMed ID: 16452236
[TBL] [Abstract][Full Text] [Related]
36. Elevated SP-1 transcription factor expression and activity drives basal and hypoxia-induced vascular endothelial growth factor (VEGF) expression in non-small cell lung cancer.
Deacon K; Onion D; Kumari R; Watson SA; Knox AJ
J Biol Chem; 2012 Nov; 287(47):39967-81. PubMed ID: 22992725
[TBL] [Abstract][Full Text] [Related]
37. hnRNPA2/B1 Ameliorates LPS-Induced Endothelial Injury through NF-
Chen Y; Tang D; Zhu L; Yuan T; Jiao Y; Yan H; Yu W
Mediators Inflamm; 2020; 2020():6458791. PubMed ID: 32565727
[TBL] [Abstract][Full Text] [Related]
38. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
[TBL] [Abstract][Full Text] [Related]
39. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneous nuclear ribonucleoproteins A1 and A2 modulate expression of Tid1 isoforms and EGFR signaling in non-small cell lung cancer.
Chen CY; Jan CI; Pi WC; Wang WL; Yang PC; Wang TH; Karni R; Wang TC
Oncotarget; 2016 Mar; 7(13):16760-72. PubMed ID: 26919236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
